| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Revolution Medicines, Inc. | Director | Common Stock | 28,815 | $778,005 | $27.00 | 16 Jun 2022 | Direct |
| Revolution Medicines, Inc. | Director | Common Stock | 19,998 | $539,946 | $27.00 | 16 Jun 2022 | Indirect |
| Revolution Medicines, Inc. | Director | Stock Option (Right to Buy) | 18,400 | 16 Jun 2022 | Direct | ||
| Maze Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 18,000 | 22 Sep 2025 | Direct | ||
| PLIANT THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 15,000 | 16 Jun 2022 | Direct | ||
| Decibel Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 10,000 | 17 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | 22 Sep 2025 | 1 | $0 | 4 | Director | 24 Sep 2025, 16:14 |
| MAZE | Maze Therapeutics, Inc. | 17 Aug 2025 | 1 | $0 | 4 | Director | 19 Aug 2025, 16:15 |
| MAZE | Maze Therapeutics, Inc. | 30 Jan 2025 | 0 | $0 | 3 | Director | 30 Jan 2025, 16:29 |
| /report/000089924322023459-exter-neil-2022-06-17 | Decibel Therapeutics, Inc. | 17 Jun 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 21 Jun 2022, 18:45 |
| PLRX | PLIANT THERAPEUTICS, INC. | 16 Jun 2022 | 1 | $0 | 4 | Director | 21 Jun 2022, 16:19 |
| RVMD | Revolution Medicines, Inc. | 16 Jun 2022 | 2 | $0 | 4 | Director | 17 Jun 2022, 17:12 |
| RVMD | Revolution Medicines, Inc. | 08 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 19:03 |
| PLRX | PLIANT THERAPEUTICS, INC. | 29 Jun 2021 | 1 | $0 | 4 | Director | 30 Jun 2021, 20:30 |
| RVMD | Revolution Medicines, Inc. | 22 Jun 2021 | 2 | $0 | 4 | Director | 24 Jun 2021, 17:18 |
| RVMD | Revolution Medicines, Inc. | 03 Jun 2021 | 2 | $0 | 4 | Director | 07 Jun 2021, 18:11 |
| RVMD | Revolution Medicines, Inc. | 25 May 2021 | 2 | $0 | 4 | Director | 27 May 2021, 17:43 |